Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2017, Article ID 9231959, 4 pages
https://doi.org/10.1155/2017/9231959
Case Report

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case

Clinic for Cardiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany

Correspondence should be addressed to Henrik Fox; ed.wrn-zdh@xofh

Received 27 February 2017; Revised 22 May 2017; Accepted 15 June 2017; Published 12 July 2017

Academic Editor: Assad Movahed

Copyright © 2017 Henrik Fox et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. P. Caforio, S. Pankuweit, E. Arbustini et al., “Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases,” European Heart Journal, vol. 34, no. 33, pp. 2636–2648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Leone, J. P. Veinot, and A. Angelini, “2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology,” Cardiovascular Pathology, vol. 21, no. 4, pp. 245–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. T. Aretz, M. E. Billingham, W. D. Edwards, S. M. Factor, J. T. Fallon, J. J. Fenoglio Jr. et al., “Myocarditis. A histopathologic definition and classification,” The American Journal of Cardiovascular Pathology, vol. 1, pp. 3–14, 1987. View at Google Scholar
  4. H. Fox, F. H. Seeger, J. Schmitt et al., “Veno-arterial ECMO as bridge to recovery. Cardiogenic shock and suspected myocarditis in a 37-year-old patient,” Medizinische Klinik - Intensivmedizin und Notfallmedizin, vol. 107, pp. 206–212, 2012. View at Google Scholar
  5. A. L. P. Caforio, F. Calabrese, A. Angelini et al., “A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis,” European Heart Journal, vol. 28, no. 11, pp. 1326–1333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Kindermann, M. Kindermann, R. Kandolf et al., “Predictors of outcome in patients with suspected myocarditis,” Circulation, vol. 118, no. 6, pp. 639–648, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Tebbe, K. Bramlage, F. John et al., “Endomyocardial biopsy in patients with cardiomyopathy of unknown origin: does specialized center experience apply to a tertiary care hospital?” BMC Research Notes, vol. 9, no. 1, pp. 1–6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tanimura, K. Dohi, K. Imanaka-Yoshida et al., “Fulminant myocarditis with prolonged active lymphocytic infiltration after hemodynamic recovery,” International Heart Journal, vol. 58, no. 2, pp. 294–297, 2017. View at Publisher · View at Google Scholar
  9. D. B. Johnson, J. M. Balko, M. L. Compton et al., “Fulminant myocarditis with combination immune checkpoint blockade,” The New England Journal of Medicine, vol. 375, pp. 1749–1755, 2016. View at Google Scholar
  10. T. Weitsman, G. Weisz, A. Keren, and T. Hasin, “Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure,” Clinical Research in Cardiology, vol. 105, no. 9, pp. 794–796, 2016. View at Publisher · View at Google Scholar · View at Scopus